Cargando…
Anti‐diabetic drugs and sarcopenia: emerging links, mechanistic insights, and clinical implications
Sarcopenia, characterized by loss of skeletal muscle mass, quality, and strength, has become a common hallmark of ageing and many chronic diseases. Diabetes mellitus patients have a higher prevalence of sarcopenia, which greatly aggravates the metabolic disturbance and compromises treatment response...
Autores principales: | Zhang, Xueli, Zhao, Yi, Chen, Shuobing, Shao, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718027/ https://www.ncbi.nlm.nih.gov/pubmed/34676695 http://dx.doi.org/10.1002/jcsm.12838 |
Ejemplares similares
-
Autophagy and Diabetic Encephalopathy: Mechanistic Insights and Potential Therapeutic Implications
por: Cheng, Li-zhen, et al.
Publicado: (2022) -
New mechanistic insight: neural cell death in diabetes-linked depression
Publicado: (2014) -
Endothelium-Dependent Hyperpolarization (EDH) in Diabetes: Mechanistic Insights and Therapeutic Implications
por: Goto, Kenichi, et al.
Publicado: (2019) -
Mechanistic insight into anti-COVID-19 drugs: recent trends and advancements
por: Tuli, Hardeep Singh, et al.
Publicado: (2021) -
Effects of anti-diabetic drugs on sarcopenia: Best treatment options for elderly patients with type 2 diabetes mellitus and sarcopenia
por: Ma, Xiao-Yu, et al.
Publicado: (2021)